Literature DB >> 2034891

Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle.

P Delatour1, F Garnier, E Benoit, I Caude.   

Abstract

Three sheep, three goats and three cattle were dosed orally with 5.0, 7.5 and 10 mg albendazole kg-1 bodyweight, respectively. Blood samples were taken at intervals for 48 hours after administration. The enantiomeric ratio of the metabolite albendazole sulphoxide (SO.ABZ) was determined by liquid chromatography on chiral stationary phases. At To, the plasma concentration ratio (+)SO.ABZ/(-)SO.ABZ was estimated at 3.0 in sheep, 1.5 in goats and 4.0 in cattle. The proportion of the (+) enantiomer then increased linearly as a function of time during the course of the kinetics. In comparison to the area under the curve for total SO.ABZ, the (+) enantiomer represented 86 per cent in sheep, 80 per cent in goats and 91 per cent in cattle. The specific behaviour of the two enantiomers is probably the result of the enantioselectivity of the flavine adenosine dinucleotide and cytochrome P450 dependent enzymatic systems which are involved in the sulphoxidation and the sulphonation of ABZ.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2034891     DOI: 10.1016/0034-5288(91)90095-6

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  9 in total

1.  Benzimidazole resistance in Haemonchus contortus recovered from farmed red deer.

Authors:  Gábor Nagy; Ágnes Csivincsik; Attila Zsolnai; László Sugár
Journal:  Parasitol Res       Date:  2016-06-01       Impact factor: 2.289

2.  Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae.

Authors:  Juan José García-Rodríguez; María Carmen Del Vegas-Sánchez; Juan José Torrado-Durán; Francisco Bolás-Fernández
Journal:  Parasitol Res       Date:  2011-08-16       Impact factor: 2.289

3.  Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

Authors:  C Gokbulut; V Y Cirak; B Senlik
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

4.  Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.

Authors:  B P Capece; G Castells; F Pérez; M Arboix; C Cristòfol
Journal:  Vet Res Commun       Date:  2000-07       Impact factor: 2.459

5.  Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  O M Takayanagui; P S Bonato; S A C Dreossi; V L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

6.  Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

Authors:  A Goudah
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

7.  Comparative pharmacokinetics and bioavailability of albendazole sulfoxide in sheep and goats, and dose-dependent plasma disposition in goats.

Authors:  Dilek Aksit; Hande Sultan Yalinkilinc; Selim Sekkin; Murat Boyacioğlu; Veli Yilgor Cirak; Erol Ayaz; Cengiz Gokbulut
Journal:  BMC Vet Res       Date:  2015-05-27       Impact factor: 2.741

8.  Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography tandem triple quadrupole mass spectrometry.

Authors:  Li Li; Dong-Xu Xing; Qing-Rong Li; Yang Xiao; Ming-Qiang Ye; Qiong Yang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

9.  Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep.

Authors:  Raquel Diez; M Jose Diez; Juan J Garcia; Jose M Rodríguez; Cristina Lopez; Nelida Fernandez; Matilde Sierra; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2022-02-14       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.